什么是权益披露？Reported on November 1st, according to the documents disclosed by the Hong Kong Stock Exchange, Weike (Hong Kong) Trading Co., Ltd. increased its shareholding on October 31st at an average price of 5.85 Hong Kong dollars per share.$BIOCYTOGEN-B (02315.HK)$1 million H-share shares, valued at approximately 5.85 million Hong Kong dollars. After the increase, Weike (Hong Kong) Trading Co., Ltd.'s latest number of shares held is 8.1026 million shares, with a warehouse ratio increasing from 6.41% to 7.31%.
What is equity disclosure?
According to the requirements of the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the company's shares) must disclose their shareholding in the listed company. Directors and senior executives of the listed company must disclose their shareholding and equity certificate rights in the listed company and any related companies.
Why is equity disclosure important?
Equity disclosure enables investors to identify (1) individuals who control or have the ability to control the shareholding of the listed company and (2) individuals who may benefit from transactions involving entities related to the listed company.
